Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies

Benzer Materyaller

• Long-term safety, tolerability and efficacy of galantamine: Results from a 36-month analysis of extension study data
  Yazar:: Wilcock, G, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.
  Yazar:: Pirttilä, T, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Galantamine in Alzheimer's disease.
  Yazar:: Razay, G, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
  Yazar:: Wilcock, G, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)
• Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
  Yazar:: Wilcock, G, ve diğerleri
  Baskı/Yayın Bilgisi: (2000)